Real-world studies have reported reduced mortality in patients with idiopathic pulmonary fibrosis (IPF) treated with antifibrotic therapy; however, the initiation or discontinuation of therapy during these studies may have introduced bias. This study investigated the effect of antifibrotic therapy on mortality and other outcomes in patients with IPF using causal inference methodology.
Dr. Murali Ramaswamy and the team from Pulmonix Research, along with Drs. Martin Portillo of Cone Health Medical Group and Praveen Mannam of LeBauer Pulmonary joined patients and others for a selfie at the Greene Street parking deck in Greensboro. The parking deck was lit in blue marking Pulmonary Fibrosis Awareness Month. Cone Health is part…
DetailsGreensboro – Dr. Patrick Wright was honored as the first recipient of the Bill Bowman Life of Service Award. Wright received the honor during the second Cone Health Physician Awards on Thursday night. The Bill Bowman Life of Service Award is named for the late general surgeon who also served as an executive at Cone Health.…
Details